For immediate release: December 11, 2020 Report From: Report Editor-in-Chief Role Commissioner for Food and Drugs – Food and Drug Administration Stephen M. Hon MD Lead Stock Director – Center for Biological Evaluation and Research (CPER) Peter Marx MD, Ph.D. Following yesterday’s positive advisory board meeting on the Pfizer-Bioentech Covit-19 vaccine, the U.S. Food and Drug Administration informed the sponsor that it will act expeditiously to finalize and issue emergency use authorization. The company has also notified U.S. Centers for Disease Control and Prevention and Operation Warp Speed, so they can implement plans for timely vaccine distribution. The FDA, within the U.S. Department of Health and Human Services, protects public health by ensuring the safety, effectiveness and security of human and veterinary drugs, vaccines and other biological products and medical devices for human use. This company is responsible for the safety and security of our country’s food supply, cosmetics, food products, electronic radiation products and tobacco products. ### Related Information Content Current: 12/11/2020 Regulated Product (s) Health Title (s)